TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase 3, Noninferiority SALSA Randomized Trial.

Josep M Llibre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.